Grenier v. Dow Chemical Co.

628 F. Supp. 1529, 21 Fed. R. Serv. 52, 1986 U.S. Dist. LEXIS 28835
District Court, D. Maine·Decided February 26, 1986·No. Civ. 84-0039 P·Published·Cited by 1 cases

Opinion

MEMORANDUM AND ORDER CONDITIONALLY GRANTING PLAINTIFF’S MOTION IN LIMINE TO ADMIT TESTIMONY OF CERTAIN COWORKERS OF THE PLAINTIFF REGARDING THEIR MEDICAL CONDITIONS

GENE CARTER, District Judge.

This is a products liability action in which Plaintiff Robert Grenier seeks to prove that he has contracted a neurological illness as a result of exposure to herbicides manufactured by the Defendant, The Dow Chemical Company. 1 Plaintiffs allege that the exposure occurred while Mr. Grenier was employed by Chem-Trol, Inc. During his employment at Chem-Trol, Mr. Grenier sprayed herbicides on utility rights of way. For the purpose of proving a causal link between the Defendant’s product and Mr. Grenier’s condition, Plaintiffs seek to introduce evidence that two of Mr. Grenier’s six coworkers are also suffering from the same neurological illness. Plaintiffs have filed a Motion in Limine to admit the testimony of these coworkers regarding their medical conditions. It is apparent from Plaintiffs’ memoranda submitted on this issue that the motion also seeks a determination of the admissibility of coworkers’ medical records and reports prepared by Plaintiffs’ experts regarding the coworkers’ medical conditions. The Court has received Defendant’s Opposition to Plaintiffs’ Motion, Plaintiffs’ Reply, Defendant’s Sur-Reply and Plaintiffs’ Response to Defendant's Sur-Reply.

Coworker Testimony

Testimony by persons other than the Plaintiff regarding injuries after exposure to an allegedly harmful product have been held to be admissible to show causation in products liability actions if the injuries and circumstances surrounding the injuries are substantially similar to the Plain *1531 tiff’s. See Kehm v. Procter & Gamble Manufacturing Company, 724 F.2d 613, 625 (8th Cir.1983) (documents and testimony of consumer relating to illness after using Rely tampons admitted under Fed.R.Evid. 401 to show “dangerousness” of product); Gober v. Revlon, Inc., 317 F.2d 47 (4th Cir.1963) (expert testimony admitted regarding other patients expert had treated who had suffered illness after using defendant’s product.) 2 Defendant relies on Amatucci v. Delaware and Hudson Railway Company, 745 F.2d 180 (2d Cir.1984), in which the Court held that it was error for the District Court to admit evidence of the number of employees who had suffered heart attacks while employed by the defendant in a lawsuit in which the plaintiff sought to prove that stressful working conditions had caused him to have a heart attack. However, as Plaintiffs correctly point out in their response to the Defendant's Sur-Reply memorandum, the evidence sought to be admitted in this instance is different in several important respects. First, while heart disease is widespread and commonly understood to be caused by many factors, in the instant matter Plaintiff’s experts will testify that Mr. Grenier’s condition is of rare incidence in the general population. Second, in Amatucci, no evidence was presented concerning the circumstances of the other employees’ illnesses. In this case, the Defendant has had full access through discovery to the medical records of the individuals involved from which to develop cross-examination as to other factors which might cause their conditions. Therefore, the Court concludes that the testimony of Mr. Grenier’s coworkers concerning their medical conditions is properly admissible if Plaintiffs establish at trial that the circumstances of the co workers exposure to the Defendant’s product and the nature of their medical conditions are substantially similar to the Plaintiff’s. 3

The Defendant asserts that the coworker group selected by the Plaintiffs is incorrect because two members of the group were exposed to a different chemical than Mr. Grenier, and two other individuals who worked with Mr. Grenier were not included in the group. Plaintiffs dispute these objections and point out that neither of the coworkers who the Defendant asserts were exposed to a different chemical have contracted the illness Mr. Grenier allegedly suffers. The Court concludes that Defendant’s objections to the composition of the coworker group arise from its characterization of the proffered coworker testimony as a flawed, and therefore inadmissible, epidemiological study. See, e.g., Kehm v. Procter & Gamble Manufacturing Company, 724 F.2d 613, 617 (1983). However, such testimony is not admitted as a valid epidemiological study, but as similar occurrences admissible under Fed.R.Evid. 401, assuming Plaintiffs provide a proper foundation. Therefore, Defendant’s objections do not render the evidence inadmissible, but are proper grounds for cross-examination at trial and may be relevant to the requisite showing of substantially similar circumstances which Plaintiffs must make in order to support the admissibility of this coworker testimony.

Medical Records and Reports Regarding Mr. Grenier’s Coworkers

Plaintiffs also seek a ruling in limine on the admissibility of the medical records of Mr. Grenier’s co workers. Since the Court has determined, in regard to *1532 coworker testimony, that the medical conditions of these coworkers are relevant if similar circumstances are demonstrated at trial, these documents are not inadmissible, as Defendant contends, on the ground of lack of relevance.

Free access — add to your briefcase to read the full text and ask questions with AI

Grenier v. Dow Chemical Co., 628 F. Supp. 1529, 21 Fed. R. Serv. 52, 1986 U.S. Dist. LEXIS 28835 (D. Me. 1986).

628 F. Supp. 1529 (Grenier v. Dow Chemical Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related